Stem cell therapy in Israel is generally safe but carries risks like localized infection, swelling, or mild pain at the injection site. Serious complications are rare in JCI-accredited facilities. Medical contraindications include active cancer, systemic infections, or severe blood disorders that may interfere with biological reconstruction outcomes.
- Procedure safety: Surgeons utilize autologous cells to eliminate donor rejection and allergic reaction risks.
- Hospital stay: Most treatments are outpatient procedures requiring 0 days of hospital immobilization.
- Clinical oversight: Specialists like Dr. Ron Arbel provide follow-up visits to monitor healing progress.
- Recovery period: Patients typically remain in Tel Aviv for 5 days for optimal monitoring.
Bookimed Expert Insight: While many countries offer stem cell treatments, Israel's Sourasky Medical Center integrates Orthokine autologous serum technology. This specific biological reconstruction involves processing the patient's own blood to produce anti-inflammatory proteins. Data shows this is particularly effective for high-level athletes, such as the Israeli national volleyball team, who require rapid joint recovery without invasive surgical risks.
Patient Consensus: Patients often feel relieved by the non-surgical nature of the treatment but suggest arranging hotel proximity carefully. The common consensus is that while the injection itself is quick, having local medical support for five days provides significant peace of mind.